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Intravenous antifungal therapy with amphotericin B is initiated empirically in patients presenting one or several characteristics that are thought to be risk factors for candidiasis or candidemia, e.g., neutropenia, chemotherapy, antibiotic treatment, positive fungal surveillance cultures, or central intravenous catheterization (4, 11, 14) . Because these factors are often present in the absence of deep fungal infection, many patients are overtreated. For instance, 40% of patients with acute leukemia but without systemic candidiasis are given amphotericin B unnecessarily (4) . Positive serological tests do not constitute a reliable indication of a deep-seated fungal infection (12) and are of little value for diagnosis in immunocompromised hosts (5) . Methods for the detection of Candida antigens or metabolites (7) have low sensitivity (1) and low positive predictive value (8) , and the value of surveillance cultures for an early diagnosis remains unclear (11) .
We report here the results of a case-control study of cancer patients with candidemia that was designed to identify clinical and microbiological risk factors for this infection. (10) . At least three blood samples were obtained for culturing at the onset of all febrile episodes (over 38.5°C for 6 h or more) and inoculated into flasks containing 100 ml of brain heart infusion broth (10 ml of blood per flask). The minimum time between blood sample collections was 2 to 3 h. Flasks were ventilated on arrival in the laboratory, and their contents were subcuItured every other day on malt agar (Roche Septi-Chek system; F. Hoffmann-La Roche, Basel, Switzerland). Isolates of Candida spp. were identified by using the API system (API system S.A., La-Balmes-les-Grottes, France).
MATERIALS AND METHODS

All
Data were managed and checked by the PIGAS system (18) and analyzed by multivariate logistic regression for matched case-control studies (3). Likelihood ratios and predictive values were calculated as described previously (15) . Gram-positive cocci 5 1 Grain-negative bacilli Characteristics of case patients and controls are given in Table 1 . Sex ratio, age, and the time that elapsed since diagnosis of the underlying disease and the start of the study were not significantly different in case patients and controls, nor were the numbers of oropharyngeal, fecal, urine, and skin cultures made during the surveillance periods. The number of samples from catheters that were cultured was larger for the case patients than for the controls, blood samples were cultured significantly more often in the case patients, and associated bacteremia was significantly more frequent.
RESULTS
In Table 2 it is shown that some clinical, therapeutic, and microbiological characteristics were significant risk factors for candidemia: the clinical risk factors were previous surgery and the durations of neutropenia and central catheterization; the therapeutic factors were exposure to chemotherapy and some antibiotic treatments; and the microbiological factors were the recovery of a Candida sp. from surveillance culture sites (oropharynx or feces). The mean fecal concentrations of Candida spp. were not significantly different, however, in the colonized case patients and colonized controls (4.1 ± 1.2 versus 3.5 ± 1.1 log1o CFU/g of feces).
Results from a multivariate analysis (Table 3) showed that, when considered together, only colonization of at least one site by a strain of Candida sp., central catheterization, and neutropenia were associated with a significantly increased risk of candidemia. Likelihood ratios calculated for these three characteristics (Table 2 ) expressed the odds that their presence would be expected in a patient with candidemia (as opposed to one without). The highest of these likelihood ratios was colonization by Candida spp.
The mortality associated with invasive disease in patients with candidemia could not be precisely assessed since an autopsy was not performed on most patients. Nevertheless, we found that only 50% of the 30 patients (cases) with candidemia survived the episode. Significantly more control patients (76%; P = 0.02) were alive at the end of the hospital stay in which the surveillance period was included. When the patients who survived were compared with those who did not for all the factors given in Tables 1 and 2, (2) , and (ii) 79% of patients with candidemia caused by C. albicans, C. tropicalis, C. pseudotropicalis, or C. krusei have proven disseminated fungal disease (12) . In studies in which conventional blood culture systems were used, only 35% of the patients with disseminated candidiasis were found to have positive blood cultures for Candida spp. (11); however, the agar slide blood culture bottles used in our study (Roche Septi-Chek system) have been shown to be significantly more sensitive than conventional blood culture bottles in detecting C. albicans bacteremia (19, 20) .
Although it could not be strictly proven, it is unlikely that our control patients had disseminated candidiasis. No blood for culture was drawn from some control patients during the surveillance period, but they remained afebrile. No blood culture from the other control patients was positive for Candida spp. These blood samples could not have been sterilized by systemic antifungal therapy, since controls were chosen among patients who did not receive such a treatment. In the multivariate analysis, we found that treatment with antibiotics was not an independent risk factor that was significantly associated with candidemia. The same result has been observed by others in non-cancer patients with candidemia (J. E. Bross, S. Hurewitz, and G. H. Talbot, Program Abstr. 26th Intersci. Conf. Antimicrob. Agents Chemother., abstr. no. 738, 1986) .
Factors associated with invasive fungal disease have been analyzed in a population that was restricted to patients undergoing induction therapy for acute myelogenous leukemia (17) . Only 55% of the fungi isolated were Candida spp. Prolonged chemotherapy and fungal colonization were the major risk factors associated with the ultimate development of invasive fungal disease, as was the case in our study. Negative peripheral cultures have also been found to be associated with the absence of systemic disease due to C. tropicalis and C. albicans (16) . Conversely, positive peripheral cultures have been associated with systemic disease caused by C. tropicalis but not by C. albicans (16) . It is usually concluded from these results that routine surveillance cultures for Candida spp. are not recommended. In groups of patients in which the prevalence of candidemia is high, however, results of such cultures might be helpful in deciding which therapy is to be used. For instance, it is usually recommended that neutropenic patients with acute leukemia and fever refractory to antibacterial agents should be treated with systemic amphotericin B (4, 14) . The prevalence of disseminated Candida infection is estimated to be 60% in these patients (4) . Calculations from the data given in Table 2 indicate that, given that prevalence, the positive predictive value of a surveillance culture which grows Candida spp. organisms reaches 83%.
We observed a 50% mortality rate in our patients with candidemia. This is similar to that given in other reports: 79% (12), 72% (9) , and 52% (6). This mortality rate was significantly higher than that observed in controls without candidemia. Therefore, our results will help to quantify the risk of candidemia in cancer patients. 
